** In Healthcare, Nasdaq Biotechnology Index posts a 10.7-pct loss as a dozen biotechs raise $1.5 bln of capital ahead of the JP Morgan conference. Co's endure plenty of pain in process with the average deal pricing at a 20-pct file-to-offer discount